NCT00418808

Brief Summary

Cerebral Palsy (CP) is a major developmental problem. Major risk groups of CP, are preterm infants and multiple pregnancies. Previous studies using the General Movements methodology demonstrated early identification of CP, as early as 3 month of age. This method was implemented mainly on preterm infants this study goal is to enlarge the scope of the methodology to infants of multiple pregnancies. A second goal is to study early motor development and its future consequences by comparing the development of the infants of the same multiple pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2007

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

January 23, 2007

Status Verified

January 1, 2007

First QC Date

January 4, 2007

Last Update Submit

January 22, 2007

Conditions

Cerebral PalsyPremature Birth

Keywords

motordevelopmentmultiple pregnanciesgeneral movementvideo recording

Eligibility Criteria

Age2 Days - 4 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm infant under 37 weeks
  • Normal or intraventricular hemorrhage grade I at U/S examination
  • No neurological family history
  • No maternal drug use with neurological effect during pregnancy
  • Normal prenatal history such as: no evidence of hypoxic ischemic encephalopathy
  • No convulsions
  • Normal karyotype
  • No major congenital heart defect
  • Dizygotic twins
  • Normal physiological examination
  • No neurological family history
  • No maternal drug use with neurological effect during pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba medical center

Tel Litwinsky, 52621, Israel

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyPremature Birth

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Omer Bar-Yosef, Dr.

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Omer Bar-Yosef, Dr.

CONTACT

972-3-5302896omerbary@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

January 4, 2007

First Posted

January 5, 2007

Study Start

August 1, 2006

Study Completion

August 1, 2009

Last Updated

January 23, 2007

Record last verified: 2007-01

Locations

IL(1)